Cargando…

Speed of leukemia development and genetic diversity in xenograft models of T cell acute lymphoblastic leukemia

T cell acute lymphoblastic leukemia (T-ALL) develops through accumulation of multiple genomic alterations within T-cell progenitors resulting in clonal heterogeneity among leukemic cells. Human T-ALL xeno-transplantation in immunodeficient mice is a gold standard approach to study leukemia biology a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Poglio, Sandrine, Lewandowski, Daniel, Calvo, Julien, Caye, Aurélie, Gros, Audrey, Laharanne, Elodie, Leblanc, Thierry, Landman-Parker, Judith, Baruchel, André, Soulier, Jean, Ballerini, Paola, Clappier, Emmanuelle, Pflumio, Françoise
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5173081/ https://www.ncbi.nlm.nih.gov/pubmed/27191650 http://dx.doi.org/10.18632/oncotarget.9313

Ejemplares similares

Clonal selection in xenografted human T cell acute lymphoblastic leukemia recapitulates gain of malignancy at relapse
por: Clappier, Emmanuelle, et al.
Publicado: (2011)

Xenograft and cell culture models of Sézary syndrome reveal cell of origin diversity and subclonal heterogeneity
por: Poglio, Sandrine, et al.
Publicado: (2020)

NKX3.1 is a direct TAL1 target gene that mediates proliferation of TAL1-expressing human T cell acute lymphoblastic leukemia
por: Kusy, Sophie, et al.
Publicado: (2010)

Ikaros deficiency is associated with aggressive BCR-ABL1 B-cell precursor acute lymphoblastic leukemia independent of the lineage and developmental origin
por: Simand, Célestine, et al.
Publicado: (2021)

Characterization of novel genomic alterations and therapeutic approaches using acute megakaryoblastic leukemia xenograft models
por: Thiollier, Clarisse, et al.
Publicado: (2012)

Therapeutic potential of ruxolitinib and ponatinib in patients with EPOR-rearranged Philadelphia chromosome-like acute lymphoblastic leukemia
por: Niswander, Lisa M., et al.
Publicado: (2021)

N-Me, a long range oncogenic enhancer in T-cell acute lymphoblastic leukemia
por: Herranz, Daniel, et al.
Publicado: (2014)

Genetic Inactivation of the PRC2 Complex in T-Cell Acute Lymphoblastic Leukemia
por: Ntziachristos, Panagiotis, et al.
Publicado: (2012)

Interleukin-18 produced by bone marrow-derived stromal cells supports T-cell acute leukaemia progression
por: Uzan, Benjamin, et al.
Publicado: (2014)

Patient-Level Meta-analysis of Clofarabine in Acute Lymphoblastic Leukemia
por: Jeha, Sima, et al.
Publicado: (2023)

Case Report: Targeting 2 Antigens as a Promising Strategy in Mixed Phenotype Acute Leukemia: Combination of Blinatumomab With Gemtuzumab Ozogamicin in an Infant With a KMT2A-Rearranged Leukemia
por: Brethon, Benoît, et al.
Publicado: (2021)

Adult Low-Hypodiploid Acute Lymphoblastic Leukemia Emerges from Preleukemic TP53-Mutant Clonal Hematopoiesis
por: Kim, Rathana, et al.
Publicado: (2023)

Preclinical Evaluation of a Novel Small Molecule Inhibitor of LIM Kinases (LIMK) CEL_Amide in Philadelphia-Chromosome Positive (BCR::ABL+) Acute Lymphoblastic Leukemia (ALL)
por: Berrou, Jeannig, et al.
Publicado: (2022)

BCR-ABL1-like acute lymphoblastic leukemia in childhood and targeted therapy
por: Cario, Gunnar, et al.
Publicado: (2020)

COVID-19 and acute lymphoblastic leukemias of children and adolescents: First recommendations of the Leukemia committee of the French Society for the fight against Cancers and Leukemias in children and adolescents (SFCE)
por: Baruchel, André, et al.
Publicado: (2020)

Efficient RNA interference in patients' acute lymphoblastic leukemia cells amplified as xenografts in mice
por: Höfig, Ines, et al.
Publicado: (2012)

Dynamic clonal progression in xenografts of acute lymphoblastic leukemia with intrachromosomal amplification of chromosome 21
por: Sinclair, Paul. B., et al.
Publicado: (2018)

The first Japanese biobank of patient‐derived pediatric acute lymphoblastic leukemia xenograft models
por: Tanaka, Kuniaki, et al.
Publicado: (2022)

COVID19 and acute lymphoblastic leukemias of children and adolescents: Updated recommendations (Version 2) of the Leukemia Committee of the French Society for the fight against Cancers and leukemias in children and adolescents (SFCE)
por: Rouger-Gaudichon, Jérémie, et al.
Publicado: (2021)

Downregulation of Glutamine Synthetase, not glutaminolysis, is responsible for glutamine addiction in Notch1‐driven acute lymphoblastic leukemia
por: Nguyen, Tra Ly, et al.
Publicado: (2021)

Somatically acquired JAK1 mutations in adult acute lymphoblastic leukemia
por: Flex, Elisabetta, et al.
Publicado: (2008)

JAK kinase inhibitors for the treatment of acute lymphoblastic leukemia
por: Degryse, Sandrine, et al.
Publicado: (2015)

Combinatorial efficacy of entospletinib and chemotherapy in patient-derived xenograft models of infant acute lymphoblastic leukemia
por: Loftus, Joseph P., et al.
Publicado: (2020)

Acute lymphoblastic leukemia
por: Schrappe, Martin
Publicado: (2018)

High tumor burden before blinatumomab has a negative impact on the outcome of adult patients with B-cell precursor acute lymphoblastic leukemia. A real-world study by the GRAALL
por: Cabannes-Hamy, Aurélie, et al.
Publicado: (2022)

TP53 alterations in primary and secondary Sézary syndrome: A diagnostic tool for the assessment of malignancy in patients with erythroderma
por: Gros, Audrey, et al.
Publicado: (2017)

UTX inhibition as selective epigenetic therapy against TAL1-driven T-cell acute lymphoblastic leukemia
por: Benyoucef, Aissa, et al.
Publicado: (2016)

An immediate transcriptional signature associated with response to the histone deacetylase inhibitor Givinostat in T acute lymphoblastic leukemia xenografts
por: Pinazza, M, et al.
Publicado: (2016)

Dissecting molecular mechanisms of resistance to NOTCH1-targeted therapy in T-cell acute lymphoblastic leukemia xenografts
por: Agnusdei, Valentina, et al.
Publicado: (2020)

Irinotecan Induces Disease Remission in Xenograft Mouse Models of Pediatric MLL-Rearranged Acute Lymphoblastic Leukemia
por: Kerstjens, Mark, et al.
Publicado: (2021)

Leukemia-Initiating Cells in T-Cell Acute Lymphoblastic Leukemia
por: Tan, Shi Hao, et al.
Publicado: (2017)

P501: ISATUXIMAB PLUS CHEMOTHERAPY FOR PEDIATRIC RELAPSED/REFRACTORY ACUTE LYMPHOBLASTIC LEUKEMIA OR ACUTE MYELOID LEUKEMIA (ISAKIDS): INTERIM EFFICACY ANALYSIS
por: Baruchel, André, et al.
Publicado: (2023)

Acute lymphoblastic leukemia in adults
por: Ribera, Josep-Maria
Publicado: (2011)

Pediatric acute lymphoblastic leukemia
por: Inaba, Hiroto, et al.
Publicado: (2020)

Granular B lymphoblastic leukemia
por: Hazarika, Biswadip, et al.
Publicado: (2022)

PHF6 mutations in T-cell acute lymphoblastic leukemia
por: Van Vlierberghe, Pieter, et al.
Publicado: (2010)

Domain II of Pseudomonas Exotoxin Is Critical for Efficacy of Bolus Doses in a Xenograft Model of Acute Lymphoblastic Leukemia
por: Müller, Fabian, et al.
Publicado: (2018)

Simultaneous Presentation of Hairy Cell Leukemia and Acute Lymphoblastic Leukemia
por: Li, Mingyong, et al.
Publicado: (2021)

TIM3, a human acute myeloid leukemia stem cell marker, does not enrich for leukemia-initiating stem cells in B-cell acute lymphoblastic leukemia
por: Bueno, Clara, et al.
Publicado: (2023)

Clinico-biological features of T-cell acute lymphoblastic leukemia with fusion proteins
por: Steimlé, Thomas, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_17orjlt0h4cdnfokbff10bsmm9